Viswanathan Mohan
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes, Cardiovascular Risks, and Lipoproteins 315
- Diabetes Management and Research 228
- Diabetes Treatment and Management 130
- Diabetes Management and Education 106
- Health Information Management top 0.05%
- Ophthalmology top 0.2%
- Physiology top 0.1%
- Epidemiology top 0.1%
- Liver Disease Diagnosis and Treatment 115
-
- Diabetes and associated disorders 184
-
- Pancreatic function and diabetes 121
-
- Metabolism, Diabetes, and Cancer 85
- Co-authors
- R DeepaRajendra PradeepaRanjit Mohan AnjanaRanjit UnnikrishnanMohan DeepaMuthuswamy BalasubramanyamVenkatesan RadhaG. Premalatha
- Journals
- Diabetes Research and Clinical Practice (62 papers)Diabetes Technology & Therapeutics (53 papers)Diabetes Care (35 papers)
- Partner nations
- IndiaUnited StatesUnited Kingdom
In The Last Decade
Viswanathan Mohan
1.2k papers receiving 37.5k citations
Hit Papers
Peers
Comparison fields: 5 of 206
- Endocrinology, Diabetes and Metabolism 17.2k
- Health Information Management 1.1k
- Ophthalmology 2.1k
- Physiology 5.8k
- Epidemiology 7.5k
Countries citing papers authored by Viswanathan Mohan
This map shows the geographic impact of Viswanathan Mohan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viswanathan Mohan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viswanathan Mohan more than expected).
Fields of papers citing papers by Viswanathan Mohan
This network shows the impact of papers produced by Viswanathan Mohan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viswanathan Mohan. The network helps show where Viswanathan Mohan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Viswanathan Mohan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 7 | |
| 10 | 2022 | 5 | |
| 11 | Risk Factors Analysis and Management of Cardiometabolic-Based Chronic Disease in Low- and Middle-Income Countries | 2022 | 6 |
| 12 | 2020 | 12 | |
| 13 | Remogliflozin Etabonate in the Treatment of Type 2 Diabetes: Design, Development, and Place in Therapy | 2020 | 4 |
| 14 | 2019 | 8 | |
| 15 | 2012 | 29 | |
| 16 | Epidemiology of hypertension in India: lessons from the Chennai Urban Population Study (CUPS). | 2007 | 2 |
| 17 | 2007 | 179 | |
| 18 | 1995 | 11 | |
| 19 | 1995 | 94 | |
| 20 | 1994 | 24 |
About Viswanathan Mohan
Viswanathan Mohan is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Health Information Management, having authored 1.2k papers that have together received 39.8k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (315 papers), Diabetes Management and Research (228 papers), Diabetes and associated disorders (184 papers), Diabetes Treatment and Management (130 papers), Pancreatic function and diabetes (121 papers), Liver Disease Diagnosis and Treatment (115 papers), Diabetes Management and Education (106 papers) and Metabolism, Diabetes, and Cancer (85 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (17.2k citations), Health Information Management (1.1k citations) and Ophthalmology (2.1k citations). Viswanathan Mohan has collaborated with scholars based in India, United States and United Kingdom. Frequent co-authors include R Deepa, Rajendra Pradeepa, Ranjit Mohan Anjana, Ranjit Unnikrishnan, Mohan Deepa, Muthuswamy Balasubramanyam, Venkatesan Radha, G. Premalatha, K.M. Venkat Narayan and M. Rema. Their work appears in journals such as Diabetes Research and Clinical Practice, Diabetes Technology & Therapeutics, Diabetes Care, Diabetic Medicine and Acta Diabetologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.